Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

Table 3 Response of SCNSL patients after induction therapy

Response	Total		New disease		Refractory disease		Relapse disease
Response	N = 19	%	N = 10	%	N = 5	%	N = 4	%
CR	11	57.9	7	70	2	40	2	50
PR	2	10.5	1	10	0	0	1	25
WBRT*	5	26.3	2	20	2	40	1	25
Death	1	5.3	0	0	1	20	0	0

CR complete remission, PR partial remission, SD stable disease, PD progression disease, WBRT whole brain radiotherapy
*WBRT indicated SCNSL who turned to WBRT during the induction treatment

ISSN: 2057-4967